| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | OSUR Orasure Technologies, Inc. | McGrath Kenneth J | Chief Financial Officer | Buy | 32,300 | $2.93 | $94,600.24 | +5.8% | - | - | |
| Mar 20, 2026 | VMD Viemed Healthcare, Inc. | Moore Michael57 | President | Sell | 136,802 | $9.05 | $1,237,976.12 | -2.7% | - | - | |
| Mar 19, 2026 | STIM Neuronetics, Inc. | Chernett Jorey | 10% Owner | Buy | 1,057,400 | $1.34 | $1,418,490.00 | +6.8% | - | - | |
| Mar 17, 2026 | HBIO Harvard Bioscience, Inc. | Denelsky Stephen J | Director | Buy | 10,000 | $4.87 | $48,700.00 | +90.9% | - | - | |
| Mar 17, 2026 | STIM Neuronetics, Inc. | Chernett Jorey | 10% Owner | Buy | 531,000 | $1.16 | $615,960.00 | +7.6% | - | - | |
| Mar 17, 2026 | HBIO Harvard Bioscience, Inc. | Snider William | Director | Buy | 21,000 | $4.93 | $103,603.50 | +60.8% | - | - | |
| Mar 16, 2026 | HBIO Harvard Bioscience, Inc. | Frost Mark T | Chief Financial Officer | Buy | 5,000 | $5.00 | $25,000.00 | +40.0% | - | - | |
| Mar 16, 2026 | MYO Myomo, Inc. | Getz Heather C46 | Director | Buy | 20,000 | $0.70 | $13,972.00 | +17.9% | - | - | |
| Mar 16, 2026 | EKSO Ekso Bionics Holdings, Inc. | Jones Jason C64 | Chief Operating Officer | Buy | 1,308 | $11.85 | $15,499.80 | +41.6% | - | - | |
| Mar 16, 2026 | EKSO Ekso Bionics Holdings, Inc. | Wong Jerome55 | Chief Financial Officer | Buy | 1,308 | $11.85 | $15,499.80 | +45.5% | - | - | |
| Mar 13, 2026 | SENS Senseonics Holdings, Inc. | Roeder Douglas A68 | Director | Buy | 17,500 | $5.73 | $100,275.00 | +17.1% | - | - | |
| Mar 13, 2026 | ATEC Alphatec Holdings, Inc. | Lish Scott60 | Chief Operating Officer | Sell | 260,535 | $12.30 | $3,204,580.50 | -24.2% | - | - | |
| Mar 13, 2026 | ATEC Alphatec Holdings, Inc. | Koning John Todd54 | Chief Financial Officer | Sell | 79,789 | $12.36 | $986,192.04 | -11.7% | - | - | |
| Mar 13, 2026 | SENS Senseonics Holdings, Inc. | Goodnow Timothy T73 | President And CEO | Buy | 17,225 | $5.79 | $99,732.75 | +2.7% | - | - | |
| Mar 13, 2026 | NMTC Neuroone Medical Technologies Corporation | Christianson Mark72 | Business Development Director | Sell | 917 | $0.80 | $733.60 | -0.2% | - | - | |
| Mar 12, 2026 | AHCO Adapthealth Corp. | Oep VII Gp, L.l.c. | 10% Owner | Buy | 2,046,691 | $9.73 | $19,912,147.84 | +4.7% | - | - | |
| Mar 12, 2026 | MYO Myomo, Inc. | Getz Heather C46 | Director | Buy | 70,000 | $0.73 | $50,960.00 | +167.6% | - | - | |
| Mar 12, 2026 | SIBN Si-Bone, Inc. | Nishimura Mika | Director | Sell | 4,100 | $13.83 | $56,700.13 | -11.1% | - | - | |
| Mar 12, 2026 | ATRC Atricure, Inc. | Doraiswamy Vinayak67 | Chief Scientific Officer | Sell | 5,000 | $29.83 | $149,150.00 | -4.9% | - | - | |
| Mar 12, 2026 | AHCO Adapthealth Corp. | Cashin Richard M Jr | 10% Owner | Buy | 2,046,691 | $9.73 | $19,912,147.84 | +4.7% | - | - | |
| Mar 11, 2026 | SERA Sera Prognostics, Inc. | Jackson Benjamin83 | General Counsel | Sell | 1,027 | $2.04 | $2,095.08 | -0.9% | - | - | |
| Mar 11, 2026 | AVHHL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 1,800 | $4.78 | $8,604.00 | +1.3% | - | - | |
| Mar 11, 2026 | EW Edwards Lifesciences Corporation | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 13,000 | $84.92 | $1,103,895.79 | -13.0% | - | - | |
| Mar 11, 2026 | BVS Bioventus Inc. | McMurry-Heath Michelle62 | Director | Sell | 12,000 | $8.79 | $105,439.20 | -21.1% | - | - | |
| Mar 11, 2026 | EW Edwards Lifesciences Corporation | Lippis Daniel J.62 | Cvp, Tavr | Sell | 1,019 | $85.38 | $87,004.46 | -2.9% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.